Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey

dc.contributor.author	Yozgat, Ayca Koca
dc.contributor.author	Leblebisatan, Goksel
dc.contributor.author	Akbayram, Sinan
dc.contributor.author	Ozel, Simge Cinar
dc.contributor.author	Karakas, Zeynep
dc.contributor.author	Erduran, Erol
dc.contributor.author	Yilmaz, Sebnem
dc.contributor.author	Kocak, Ulker
dc.contributor.author	Unal, Sule
dc.contributor.author	Ozdemir, Gul Nihal
dc.contributor.author	Albayrak, Meryem
dc.date.accessioned	2021-12-21T08:47:57Z
dc.date.available	2021-12-21T08:47:57Z
dc.date.issued	2020
dc.identifier.issn	1300-7777
dc.identifier.issn	1308-5263
dc.identifier.uri	https://doi.org/10.4274/tjh.galenos.2020.2019.0380
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2328
dc.description.abstract	Objective: Immune thrombocytopenia (ITP) is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in significant symptoms, such as bleeding, bruising, epistaxis, or petechiae. The thrombopoietin recept
dc.language.iso	English
dc.publisher	Galenos Yayıncılık
dc.rights	gold, Green Published
dc.title	Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey
dc.type	Article
dc.relation.journal	Turkısh Journal Of Hematology
dc.identifier.issue	3
dc.identifier.startpage	139
dc.identifier.endpage	144
dc.identifier.volume	37
dc.identifier.doi	10.4274/tjh.galenos.2020.2019.0380
dc.relation.issue	3
dc.relation.volume	37